Shots:

• The US FDA has permitted marketing of a device intended for the temporary reduction of sleep disturbance related to nightmares in patients aged ≥22 yrs. suffering from nightmare disorder or PTSD
• Nightware utilizes Apple Watch and an iPhone that is configured and logged into a software application and the Nightware server and monitors the wearer’s HR and movement while they sleep and if they are having a nightmare- gently arouse them out of the dream without waking up completely- using the smartwatch’s vibrations
• The platform received the US FDA’s BT designation in May’2019 and now is available by prescription only and is intended for home use

 ­ Ref: FDA | Image: IT PRO